Cardiac involvement in progressive muscular dystrophy of the Duchenne type
- PMID: 9201104
- DOI: 10.1536/ihj.38.163
Cardiac involvement in progressive muscular dystrophy of the Duchenne type
Abstract
Duchenne's progressive muscular dystrophy (DMD) is a genetic muscle disorder that causes degeneration and atrophy of the systemic and cardiac muscle. The disease is manifested early in childhood, and most of patients die by age 20 years of respiratory failure or heart failure. The cardiac involvement in DMD is characterized pathologically by degeneration and fibrosis of the myocardium, centering around the posterolateral wall of the left ventricle. Functionally, an abnormal electrocardiogram, valve motion, wall thickness, and wall motion are observed. Furthermore, abnormalities in plasma levels of atrial natriuretic peptide and autonomic function are also demonstrated. In this review, the cardiac involvements in DMD in the following aspects are described: 1) Electrocardiogram; a) high-frequency notches on the QRS complexes, b) amplitude of QRS complexes, c) late potential, d) arrhythmias, e) heart rate variability, f) a 10-year follow-up study, 2) Echocardiographic findings, 3) Hemodynamic findings, 4) Atrial natriuretic peptide.
Similar articles
-
Plasma levels of atrial natriuretic peptide in patients with Duchenne's progressive muscular dystrophy.Am Heart J. 1990 Nov;120(5):1154-8. doi: 10.1016/0002-8703(90)90130-p. Am Heart J. 1990. PMID: 2146865
-
The heart in human dystrophinopathies.Cardiology. 2003;99(1):1-19. doi: 10.1159/000068446. Cardiology. 2003. PMID: 12589117 Review.
-
Sequence of cardiac changes in Duchenne muscular dystrophy.Am Heart J. 1978 Mar;95(3):283-94. doi: 10.1016/0002-8703(78)90358-7. Am Heart J. 1978. PMID: 622971
-
Cardiac rhythm and conduction in Duchenne's muscular dystrophy: a prospective study of 20 patients.J Am Coll Cardiol. 1984 May;3(5):1263-8. doi: 10.1016/s0735-1097(84)80186-2. J Am Coll Cardiol. 1984. PMID: 6707378
-
The Added Value of Cardiac Magnetic Resonance in Muscular Dystrophies.J Neuromuscul Dis. 2019;6(4):389-399. doi: 10.3233/JND-190415. J Neuromuscul Dis. 2019. PMID: 31561382 Free PMC article. Review.
Cited by
-
Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.Pediatr Cardiol. 2008 Mar;29(2):343-51. doi: 10.1007/s00246-007-9113-z. Epub 2007 Sep 21. Pediatr Cardiol. 2008. PMID: 17885779 Clinical Trial.
-
Electrocardiographic features of children with Duchenne muscular dystrophy.Orphanet J Rare Dis. 2022 Aug 20;17(1):320. doi: 10.1186/s13023-022-02473-9. Orphanet J Rare Dis. 2022. PMID: 35987773 Free PMC article. Review.
-
Cardiopulmonary support in duchenne muscular dystrophy.Lung. 2006 Jul-Aug;184(4):205-15. doi: 10.1007/s00408-005-2584-x. Lung. 2006. PMID: 17006747 Review.
-
Patchy or homogenous myocardial fibrosis in Becker muscular dystrophy? Comments on Süselbeck et al., Z Kardiol 94:465-468/2005.Clin Res Cardiol. 2006 Apr;95(4):244-5; author reply 245-6. doi: 10.1007/s00392-006-0366-y. Clin Res Cardiol. 2006. PMID: 16598596 No abstract available.
-
Arrhythmic Risk Stratification and Sudden Cardiac Death Prevention in Duchenne Muscular Dystrophy: A Critical Appraisal.Rev Cardiovasc Med. 2025 Mar 11;26(3):27089. doi: 10.31083/RCM27089. eCollection 2025 Mar. Rev Cardiovasc Med. 2025. PMID: 40160579 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical